• Latrunculin A: Reversible Inhibitor of Actin Assembly in Cel

  2026-04-21

  Latrunculin A, a rapid and reversible inhibitor of actin assembly, is reshaping how researchers dissect cytoskeletal dynamics and cell motility. This article spotlights hands-on workflows, comparative advantages, and troubleshooting for harnessing APExBIO's Latrunculin A in advanced cytoskeleton research.

• Gentamycin Sulfate: Strategic Leverage for Resistance Resear

  2026-04-20

  Explore how Gentamycin Sulfate empowers translational researchers with mechanistic precision and strategic flexibility to dissect bacterial protein synthesis, model antibiotic resistance, and inform next-generation Gram-negative pathogen control. This thought-leadership article bridges rigorous molecular insight with actionable experimental guidance, situates Gentamycin Sulfate within the competitive antimicrobial research landscape, and looks ahead to future advances in the fight against multidrug-resistant bacteria.

• Pioglitazone: PPARγ Agonist for Metabolic and Inflammatory R

  2026-04-20

  Pioglitazone is a selective PPARγ agonist with high-affinity ligand binding, enabling robust dissection of glucose and lipid metabolism in preclinical models. It modulates macrophage polarization and attenuates inflammatory processes via STAT-1/STAT-6 pathway regulation. This dossier provides machine-readable, evidence-rich guidance for type 2 diabetes mellitus research and beyond.

• DNA Damage Sensing and TP53 Shape Calicheamicin Sensitivity

  2026-04-19

  This study systematically mapped genetic determinants of sensitivity to calicheamicin-based antibody–drug conjugates (ADCs) in acute leukemia, identifying TP53, ATM, and MDM2 as critical modulators. The findings provide a mechanistic foundation for rational combination therapies designed to overcome resistance to ADCs such as gemtuzumab ozogamicin and inotuzumab ozogamicin.

• Estradiol Modulates Splenic CD4+ T Cells via ER-α and GPR30

  2026-04-18

  This study demonstrates that estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress (ERS) through ER-α and GPR30, but not ER-β. The findings clarify mechanistic pathways of immune modulation and highlight the functional specificity of estrogen receptor subtypes in trauma-induced immune dysfunction.

• A-769662: AMPK Activator Workflows for Metabolic Research

  2026-04-17

  A-769662, a potent AMPK activator, enables precise regulation of energy metabolism, fatty acid synthesis, and autophagy in disease models. This guide bridges novel mechanistic insights with practical protocols, highlighting troubleshooting strategies and comparative workflow advantages for metabolic, diabetes, and proteasome-related research.

• Cy5 TSA Fluorescence System Kit: Ultra-Sensitive Signal Ampl

  2026-04-16

  Unlock single-cell precision and robust detection of low-abundance targets with the Cy5 TSA Fluorescence System Kit. This advanced system accelerates immunohistochemistry and in situ hybridization workflows, offering up to 100-fold signal amplification while preserving specificity.

• Pharmacokinetics of CSBTA in MASH: Tissue Distribution and V

  2026-04-15

  This study provides a detailed pharmacokinetic analysis of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of metabolic dysfunction-associated steatohepatitis (MASH). The findings reveal how disease state and dosing regimens alter systemic exposure and hepatic accumulation of key alkaloids, informing rational design of MASLD/MASH interventions.

• Partial BACE1 Inhibition Reduces Amyloid Beta Without Synapt

  2026-04-14

  Satir et al. (2020) demonstrate that partial inhibition of BACE1 can lower amyloid beta production by up to 50% without compromising synaptic transmission in cultured neurons. This finding suggests a feasible therapeutic window for BACE inhibitors in Alzheimer's disease research, supporting moderate dosing strategies to minimize adverse effects.

• Renal Secretion Mechanism of Faropenem via Npt1 Transporter

  2026-04-13

  This study uncovers the molecular mechanism by which the penem antibiotic faropenem is secreted across the renal tubular epithelium, demonstrating that the inorganic phosphate transporter Npt1 is a key facilitator of this process. These insights provide a pharmacokinetic foundation for optimizing faropenem use in both clinical and experimental research, particularly for studies involving antibiotic resistance and spectrum of activity.

• Estradiol, GPR30, and ER Stress: Modulating Splenic CD4+ T C

  2026-04-12

  This study establishes that 17β-estradiol restores splenic CD4+ T lymphocyte proliferation after hemorrhagic shock by inhibiting endoplasmic reticulum stress, via both ERα and GPR30 pathways. The work highlights the critical non-genomic estrogen signaling axis in immune recovery, with implications for precise pharmacological targeting in trauma-induced immunosuppression.

• Cyclic Pifithrin-α Hydrobromide: Reliable p53 Inhibition for

  2026-04-12

  Cyclic Pifithrin-α hydrobromide (SKU A4477) stands out as a potent p53 inhibitor, enabling researchers to achieve reproducible apoptosis inhibition and DNA damage response modulation in both cancer and neuroinflammatory models. This article details real-world laboratory scenarios, quantitative parameters, and validated best practices, positioning A4477 as the tool of choice for sensitive and robust experimental workflows.

• Applied Strategies for CA-074: Cathepsin B Inhibitor in Cell

  2026-04-11

  Unlock the power of CA-074, a highly selective cathepsin B inhibitor, to dissect necroptosis pathways and suppress cancer metastasis with precision. Learn how to optimize workflows, troubleshoot common pitfalls, and leverage the latest mechanistic insights for robust, reproducible results across oncology and neurodegeneration research.

• 3X (DYKDDDDK) Peptide: Precision Tag for FLAG Fusion Workflo

  2026-04-11

  The 3X (DYKDDDDK) Peptide streamlines affinity purification and immunodetection for recombinant proteins, supporting advanced workflows from structural studies to metal-sensitive ELISA. Discover its robust performance, troubleshooting strategies, and insights from FGFR2 fusion research driving next-generation assay design.

• Redefining Tumor Suppressor Restoration: Mechanistic and ...

  2026-04-10

  This thought-leadership article explores the mechanistic, experimental, and translational frontiers of using EZ Cap™ Human PTEN mRNA (ψUTP) for precise restoration of tumor suppressor PTEN in cancer research. By integrating recent breakthroughs in nanoparticle-mediated mRNA delivery and the suppression of PI3K/Akt signaling, we provide strategic guidance for translational researchers seeking to leverage next-generation mRNA reagents for resistance reversal and gene therapy innovation.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page